BRANFORD, CT, USA I May 28, 2025 I Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies ...

(“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that its research ...

SHENZHEN, China I May 28, 2025 I On May 26th, Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved ...

INDICATIONS AND USAGE TRYPTYR (acoltremon ophthalmic solution) 0.003% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).

Favorable safety and tolerability, with promising early activity of novel mRNA-based therapy observed from interim data– ...

WHIPPANY, NJ, USA I May 28, 2025 I Bayer announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application ...

MUNICH, Germany and WILMINGTON, DE, USA I May 28, 2025 I DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug ...

Financing led by Novo Holdings with significant support from world-class group of existing and new investors Proceeds from financing to support development of first-in-class IgG4-targeted protein ...

Collaboration leverages City Therapeutics’ next-generation RNAi engineering technologies and Biogen’s extensive drug development expertise ...

Study will assess relative efficacy, safety, and immunogenicity of Vaxart’s oral pill COVID-19 vaccine candidate against an approved mRNA comparator at 12 ...

HAMILTON, Bermuda I May 27, 2025 I Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB:CYTOF), a company dedicated to developing and ...

JENA, Germany I May 28, 2025 I InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the ...